In 2025, side hustles are becoming increasingly popular, with more people taking on extra work alongside their main jobs to boost their income or explore turning their passions...
Keep Reading →
July 10 - Dividend Stocks, Hedge Funds, News
Bristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio.
Keep Reading →
July 9 - News
On Tuesday’s episode of Mad Money, host Jim Cramer remarked that the market is currently undergoing what he described as a “countertrend” rally, as investors appear to be...
Keep Reading →
July 3 - Hedge Funds, News
Ray Dalio began his investing journey at just 12 years old and went on to gain experience at institutions such as the New York Stock Exchange, Dominick & Dominick LLC, and Shearson...
Keep Reading →
June 30 - Hedge Funds, News
Bristol-Myers Squibb Company (NYSE:BMY) ranks among the top stocks for an early retirement portfolio.
Keep Reading →
June 25 - News
Bristol-Myers Squibb Company (NYSE:BMY) is the third biopharmaceutical company on the list of the 10 undervalued blue chip stocks analysts recommend for smart investing.
Keep Reading →
June 24 - News
This week, Federal Reserve officials have the opportunity to discuss their views on interest rate trends, the effects of tariffs, and the economic effects of the Middle East crisis...
Keep Reading →
June 24 - Hedge Funds, News, Retirement
Blue-chip stocks are great assets for investors looking for opportunities to grow their capital in the long term. Some call them steady oaks in the forest of finance.
Keep Reading →
June 20 - Hedge Funds, News
Bristol-Myers Squibb Company (NYSE:BMY) is one of the 15 best stocks to invest in for an 18 year old.
Keep Reading →
June 17 - News
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best stocks to buy for beginners now.
Keep Reading →
June 17 - News
On June 12, Dan Niles, Niles Investment Management founder and portfolio manager, joined CNBC's 'Squawk Box' to discuss the state of the economy and how he expects the market ...
Keep Reading →
June 16 - Hedge Funds, News
Bristol-Myers Squibb Company (NYSE:BMY) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds.
Keep Reading →
June 15 - News
Bristol-Myers Squibb Company (NYSE:BMY) is one of the 17 stocks that Jim Cramer commented on.
Keep Reading →
June 15 - Hedge Funds, News
Health and Human Services Secretary Robert F. Kennedy Jr.
Keep Reading →
June 13 - News
The Bureau of Labor Statistics stated on June 11 that consumer prices increased less than anticipated in May given that President Donald Trump's tariffs had not yet had a noticeable...
Keep Reading →
June 12 - Hedge Funds, News
On Friday, Mad Money host Jim Cramer shared his evolving view of Elon Musk’s company as he provided both praise and caution in light of recent developments involving Musk and...
Keep Reading →
June 11 - Hedge Funds, News
We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at where Bristol-Myers Squibb Co.
Keep Reading →
June 6 - News
During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies depend on China, during a time when the U.S.
Keep Reading →
June 5 - Hedge Funds, News
Bristol-Myers Squibb Company (NYSE:BMY), which focuses on innovative cancer and immunology treatments, is a leader in the global biopharmaceutical market.
Keep Reading →
June 2 - News
On Monday, June 2, Bloomberg reported that Bristol-Myers Squibb Company (NYSE:BMY) and BioNTech SE (NASDAQ:BNTX) announced a strategic licensing agreement focused on next-generation...
Keep Reading →
June 2 - News
“Let's get started with the stocks that sold off hard today, because I think it's really important, because you know most, if not all, of these companies.
Keep Reading →
May 16 - Hedge Funds, News
“When interest rates go up, even if they go up just a little, you can see lots of very good well-known stocks with juicy dividends just get pummeled.
Keep Reading →
May 16 - Hedge Funds, News
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
Keep Reading →
May 12 - Hedge Funds, Industries, News
Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies.
Keep Reading →
May 9 - Dividend Stocks, Hedge Funds, News
“Alright, look, lately, we can’t go a day without hearing some widespread misperceptions about stock ownership. I gotta tell you, I think it’s infuriating.
Keep Reading →
May 4 - Hedge Funds, News
Jim Cramer in a latest program on CNBC talked about the latest signs of de-escalation in trade wars between the US and China and told investors that even bear market rallies could...
Keep Reading →
April 30 - Hedge Funds, News
Dividend stocks are increasingly popular with both every day and billionaire investors.
Keep Reading →
April 27 - Dividend Stocks, Hedge Funds, News
Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC that the market isn’t done going down and urged investors not to buy every dip ...
Keep Reading →
April 27 - Hedge Funds, News
Bristol-Myers Squibb Company (NYSE:BMY) Q1 2025 Earnings Call Transcript April 24, 2025Bristol-Myers Squibb Company beats earnings expectations.
Keep Reading →
April 25 - News, Transcripts
Value stocks are enjoying a rare period of strength amid this year’s broader market downturn.
Keep Reading →
April 23 - Dividend Stocks, Hedge Funds, News
Threats of an impending recession are looming over the stock market due to Trump's tariffs and macroeconomic uncertainty.
Keep Reading →
April 22 - Hedge Funds, News
The stock market has been experiencing volatility and has quickly shifted from the post-election highs to being priced for recession.
Keep Reading →
April 16 - Hedge Funds, News
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
Keep Reading →
April 14 - Hedge Funds, News
Dividends, though sometimes underappreciated, have significantly contributed to long-term investor gains.
Keep Reading →
April 14 - Dividend Stocks, Hedge Funds, News
Some experts view medical, healthcare, and big pharma stocks as immune from trade carnage, making them a safe haven amid the uncertainty brought about by Trump's tariffs.
Keep Reading →
April 10 - Hedge Funds, Industries, News
Amid growing concerns about economic growth and President Trump's tariffs, investors have been seeking safer investment options.
Keep Reading →
April 9 - Dividend Stocks, Hedge Funds, News
On his appearance on CNBC's Squawk on the Street on Thursday, Jim Cramer commented on the global response to President Trump's tariffs.
Keep Reading →
April 7 - Market Movers, News
Dividend investing appears to be a simple strategy on the surface, but in reality, it requires a much deeper analysis.
Keep Reading →
March 31 - Hedge Funds, News
Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI.
Keep Reading →
March 30 - Hedge Funds, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed his takeaways from last week's GTC conference.
Keep Reading →
March 27 - News
Billionaire investor and CEO of Berkshire Hathaway Warren Buffett sold a record $134 billion worth of stock in 2024.
Keep Reading →
March 20 - Hedge Funds, News
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
Keep Reading →
March 20 - Dividend Stocks, Hedge Funds, News
On February 21, Jared Holz, Mizuho Securities America's healthcare sector strategist, appeared on CNBC to discuss Trump's tariffs and their effects on the American pharma sector...
Keep Reading →
March 17 - Hedge Funds, Industries, News
Identifying undervalued stocks in an uncertain market environment is both a challenge and an opportunity for investors.
Keep Reading →
March 17 - Hedge Funds, News
We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BMY.
Keep Reading →
March 17 - News, Stock Analysis
Value investing has long been a preferred strategy among investors, largely influenced by Warren Buffett, who continues to seek out stocks he believes are trading below their ...
Keep Reading →
March 14 - Dividend Stocks, Hedge Funds, News
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Keep Reading →
March 11 - Hedge Funds, Industries, News
Dividend stocks have taken a backseat in the market as technology and AI-driven equities have soared to record highs.
Keep Reading →
March 7 - Dividend Stocks, Hedge Funds, News
Value investing has remained a favored approach among investors for years, largely popularized by Warren Buffett, who continues to focus on stocks he believes are undervalued ...
Keep Reading →
March 6 - Dividend Stocks, Hedge Funds, News
Jim Cramer in a latest program on CNBC said that pain is “inevitable” in the stock market as investors go through the volatility infused by the latest tariffs announced by...
Keep Reading →
March 5 - Hedge Funds, News